Oxford BioMedica PLC
LSE:OXB

Watchlist Manager
Oxford BioMedica PLC Logo
Oxford BioMedica PLC
LSE:OXB
Watchlist
Price: 412.5 GBX -1.43% Market Closed
Market Cap: 434.6m GBX
Have any thoughts about
Oxford BioMedica PLC?
Write Note

Oxford BioMedica PLC
Net Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Oxford BioMedica PLC
Net Income Peer Comparison

Comparables:
CNTA
AUTL
BCYC
IMCR
GNS

Competitive Net Income Analysis
Latest Figures & CAGR of Competitors

Company Net Income CAGR 3Y CAGR 5Y CAGR 10Y
Oxford BioMedica PLC
LSE:OXB
Net Income
-ÂŁ171.9m
CAGR 3-Years
N/A
CAGR 5-Years
-157%
CAGR 10-Years
-31%
Centessa Pharmaceuticals PLC
NASDAQ:CNTA
Net Income
-$151.1m
CAGR 3-Years
-142%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Autolus Therapeutics PLC
NASDAQ:AUTL
Net Income
-$208.4m
CAGR 3-Years
-14%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Bicycle Therapeutics PLC
NASDAQ:BCYC
Net Income
-$166.3m
CAGR 3-Years
-36%
CAGR 5-Years
-38%
CAGR 10-Years
N/A
Immunocore Holdings PLC
NASDAQ:IMCR
Net Income
-ÂŁ55.3m
CAGR 3-Years
9%
CAGR 5-Years
5%
CAGR 10-Years
N/A
Genus PLC
LSE:GNS
Net Income
ÂŁ2.4m
CAGR 3-Years
-63%
CAGR 5-Years
-19%
CAGR 10-Years
-22%

See Also

What is Oxford BioMedica PLC's Net Income?
Net Income
-171.9m GBP

Based on the financial report for Jun 30, 2024, Oxford BioMedica PLC's Net Income amounts to -171.9m GBP.

What is Oxford BioMedica PLC's Net Income growth rate?
Net Income CAGR 10Y
-31%

Over the last year, the Net Income growth was -142%.

Back to Top